Mind Medicine (MindMed) Inc.
MNMD
$9.85
-$0.34-3.34%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.04% | -17.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 27.19% | -0.93% | |||
| Operating Income | -27.19% | 0.93% | |||
| Income Before Tax | -83.07% | 32.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -83.07% | 32.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -83.07% | 32.79% | |||
| EBIT | -27.19% | 0.93% | |||
| EBITDA | -27.20% | 0.95% | |||
| EPS Basic | -82.44% | 33.68% | |||
| Normalized Basic EPS | -82.51% | 33.71% | |||
| EPS Diluted | -43.74% | 16.05% | |||
| Normalized Diluted EPS | -86.75% | 35.21% | |||
| Average Basic Shares Outstanding | 0.33% | 1.35% | |||
| Average Diluted Shares Outstanding | -2.00% | 3.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||